Pembrolizumab vs Sumatriptan

## Pembrolizumab vs Sumatriptan: Overview

This comparison examines the pharmacological differences between **Pembrolizumab** and **Sumatriptan**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

**Sumatriptan**: Selective 5-HT1B/1D receptor agonist.

## Pharmacokinetics

**Half-life**: Pembrolizumab — 26 days; Sumatriptan — 2.5 hours.

## Chemical Properties

**Molecular Formula**: Pembrolizumab — N/A; Sumatriptan — C14H21N3O2S.

**Molecular Weight**: Pembrolizumab — N/A; Sumatriptan — 295.4020 g/mol.

**Type**: Pembrolizumab — Antibody; Sumatriptan — Small molecule.